What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design. (January 2013)

Record Type:: Journal Article
Title:: What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design. (January 2013)
Main Title:: What the new US FDA guidance in assessing suicidal ideation and behavior in clinical trials means for trial design
Authors:: Morris, David W
Abstract:
Is Part Of:: Clinical investigation. Volume 3:Number 1(2013)
Journal:: Clinical investigation
Issue:: Volume 3:Number 1(2013)
Issue Display:: Volume 3, Issue 1 (2013)
Year:: 2013
Volume:: 3
Issue:: 1
Issue Sort Value:: 2013-0003-0001-0000
Page Start:: 9
Page End:: 12
Publication Date:: 2013-01
Subjects:: C-CASA -- C-SSRS -- clinical trials -- US FDA guidance -- FDA warning -- suicidality -- suicidal behavior -- suicidal ideation
Drugs -- Testing -- Periodicals
Drug development -- Periodicals
Clinical trials -- Periodicals
615.580724
Journal URLs:: http://www.future-science.com/loi/cli ↗
http://www.future-science.com/ ↗
DOI:: 10.4155/cli.12.142 ↗
Languages:: English
ISSNs:: 2041-6806
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16449.xml